SAN - Banco Santander, S.A.

NYSE - Nasdaq Real Time Price. Currency in USD
4.5500
+0.2200 (+5.08%)
As of 11:31AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close4.3300
Open4.5000
Bid4.55 x 21500
Ask4.56 x 28000
Day's Range4.4900 - 4.5700
52 Week Range4.3000 - 7.5700
Volume5,695,842
Avg. Volume8,365,834
Market Cap74.075B
Beta (3Y Monthly)1.05
PE Ratio (TTM)9.44
EPS (TTM)0.48
Earnings DateJan 25, 2017 - Feb 1, 2017
Forward Dividend & Yield0.16 (3.58%)
Ex-Dividend Date2018-10-16
1y Target Est6.04
Trade prices are not sourced from all markets
  • Reuters6 hours ago

    CEE MARKETS-Stocks rebound, crown eases despite rate hike suggestion

    Warsaw led a rise of Central Europe's main stock indices on Wednesday as U.S. President Donald Trump generated optimism about a trade deal with China, helping global equities markets. Warsaw's bluechip ...

  • Reuters22 hours ago

    Santander Brasil CFO expects asset growth of up to 8 pct in 2019

    Banco Santander Brasil may expand its assets by up to 8 percent next year, above the country's GDP growth rate, Chief Financial Officer Angel Santodomingo told investors on Tuesday. The announcement comes ...

  • Reuters4 days ago

    Julius Baer in talks with Santander over Venezuela business: sources

    Swiss private bank Julius Baer is in talks about transferring its Venezuelan book of business to Spain's Banco Santander as Baer reorganises operations in Latin America, sources close to the situation have told Reuters. Baer said in October it was closing its branches in Peru and Panama as part of its effort to focus on larger markets in the region such as Mexico, Brazil and Argentina. A source familiar with the situation, who asked not to be identified, said on Saturday that talks with Santander over Baer's Venezuelan book of business were under way but had not yet been concluded.

  • Julius Baer in talks with Santander over Venezuela business: sources
    Reuters4 days ago

    Julius Baer in talks with Santander over Venezuela business: sources

    Swiss private bank Julius Baer (BAER.S) is in talks about transferring its Venezuelan book of business to Spain's Banco Santander (SAN.MC) as Baer reorganizes operations in Latin America, sources close to the situation have told Reuters. Baer said in October it was closing its branches in Peru and Panama as part of its effort to focus on larger markets in the region such as Mexico, Brazil and Argentina. A source familiar with the situation, who asked not to be identified, said on Saturday that talks with Santander over Baer's Venezuelan book of business were under way but had not yet been concluded.

  • Reuters7 days ago

    Spanish online bank WiZink looks to float in 2019 -sources

    FRANKFURT/LONDON/MADRID, Dec 5 (Reuters) - Investment firm Varde Partners is planning to float its Spanish online bank WiZink next year, with investment banks UBS and Goldman Sachs likely to be selected as IPO coordinators, people close to the matter said. WiZink is expected to have a market capitalisation of around 2.5-3 billion euros ($2.8-$3.4 billion) and the initial public offering (IPO) would come in the third quarter of 2019, one of the sources added. Goldman Sachs and WiZink declined to comment, while UBS did not immediately respond to a request for comment.

  • Santander Bank Names David Harnisch Head of Commercial Banking
    PR Newswire9 days ago

    Santander Bank Names David Harnisch Head of Commercial Banking

    BOSTON, Dec. 3, 2018 /PRNewswire/ -- Santander Bank today announced that it has named David Harnisch Head of Commercial Banking. Harnisch joined Santander in 2017 as the Head of Underwriting, Portfolio Management and Commercial Strategy, and will now be responsible for leading and growing its commercial banking division.

  • Moody's9 days ago

    GUINCHO FINANCE -- Moody's assigns definitive ratings to Guincho Finance Portuguese ABS notes backed by NPLs issued by Hefesto, STC, S.A.

    Rating Action: Moody's assigns definitive ratings to Guincho Finance Portuguese ABS notes backed by NPLs issued by Hefesto, STC, S.A. Moody's has not assigned any ratings to E25,000,000 Class J Asset-Backed Variable Return Notes due November 2038 and E3,100,000 Class R Notes due November 2038. The NPLs consist of defaulted secured loans, equal to E234.8 million, which are backed by residential, commercial/industrial properties and land located in Portugal.

  • Financial Times10 days ago

    [$$] Santander targets super-rich in three-year expansion plan

    Santander is ramping up its focus on the ultra-wealthy as the global bank puts more resources into its private wealth arm, with the aim of adding tens of billions to its assets under management within the next three years. The wealthy in other countries such as the UK and the US, where Santander’s private bank is weaker, will be targeted through the bank’s retail network and its presence in Miami. Victor Matarranz, the head of the wealth management division, said that the bank would aim for “organic” growth rather than acquisitions to achieve its goals — though these remained an option.

  • Santander Sees Brazil Poised for $30 Billion Equity Sale Bonanza
    Bloomberg13 days ago

    Santander Sees Brazil Poised for $30 Billion Equity Sale Bonanza

    “2019 is going to be a quite active year,” said Santander Brasil’s head of Equities Andre Rosenblit. This scenario has changed,” Rosenblit said in an interview at the bank’s Sao Paulo office. The outlook’s shift for equity offerings in Latin America’s largest economy has taken place amid investors’ expectations that President-elect Jair Bolsonaro’s administration will embrace a market-friendly agenda, aiming to privatize inefficient state-owned companies and pushing through fiscal measures to fix the country’s rising public debt, especially an overhaul in Brazil’s social security system.

  • Moody's15 days ago

    FONDO DE TITULIZACION PYMES SANTANDER 14 -- Moody's assigns definitive ratings to SME ABS notes issued by FONDO DE TITULIZACION PYMES SANTANDER 14

    The ratings of the Notes are primarily based on the analysis of the credit quality of the underlying portfolio, the structural integrity of the transaction, the roles of external counterparties and the protection provided by credit enhancement. The Notes' ratings are sensitive to the performance of the underlying portfolio, which in turn depends on economic and credit conditions that may change.

  • Is Banco Santander SA (BME:SAN) A Smart Pick For Income Investors?
    Simply Wall St.16 days ago

    Is Banco Santander SA (BME:SAN) A Smart Pick For Income Investors?

    A sizeable part of portfolio returns can be produced by dividend stocks due to their contribution to compounding returns in the long run. Historically, Banco Santander SA (BME:SAN) has been Read More...

  • Moody's19 days ago

    FONDO DE TITULIZACION PYMES SANTANDER 13 -- Moody's upgrades FONDO DE TITULIZACION PYMES SANTANDER 13 Class A and B notes

    Pymes Santander 13 is a cash securitisation of standard loans and credit lines granted by Banco Santander S.A. (Spain) ("Santander", Long Term Deposit Rating: A2 Not on Watch /Short Term Deposit Rating: P-1 Not on Watch) to small and medium-sized enterprises (SMEs) and self-employed individuals located in Spain. The upgrade is prompted by the increase in the credit enhancement (CE) available for the affected tranche due to portfolio amortization. Class A credit enhancement level has increased to 31% from 21.5% observed at last rating action in May 2018, a 49% increase in relative terms since the closing date of the transaction in January 2018.

  • Reuters22 days ago

    U.S. watchdog fines Spain's Santander $11.8 mln over misleading loans, insurance

    Santander Consumer USA Holdings Inc, a leading subprime auto lender, will pay $11.8 million to settle claims that it misled customers about the cost and terms of auto loans and insurance, a U.S. consumer watchdog said on Tuesday. Santander Consumer, an affiliate of the Spanish banking group Banco Santander SA, promised drivers lower monthly fees by allowing them to make interest-only payments without explaining this would increase the total cost of the loan, the Consumer Financial Protection Bureau (CFPB) said. Santander Consumer is one of the nation's largest subprime auto lenders and manages about $52 billion in loans to 2.7 million customers, the lender has said.

  • BBVA or SAN: Which Is the Better Value Stock Right Now?
    Zacks22 days ago

    BBVA or SAN: Which Is the Better Value Stock Right Now?

    BBVA vs. SAN: Which Stock Is the Better Value Option?

  • Moody's22 days ago

    FONDO DE TITULIZACION PYMES SANTANDER 14 -- Moody's assigns provisional ratings to SME ABS notes to be issued by FONDO DE TITULIZACION PYMES SANTANDER 14

    Moody's issues provisional ratings in advance of the final sale of financial instruments, but these ratings only represent Moody's preliminary credit opinions. The transaction is a cash securitisation of standard loans and credit lines granted by Banco Santander S.A. (Spain) ("Santander", Long Term Deposit Rating: A2 Not on Watch /Short Term Deposit Rating: P-1 Not on Watch) mainly to small and medium-sized enterprises (SMEs) and self-employed individuals located in Spain. The ratings of the Notes are primarily based on the analysis of the credit quality of the underlying portfolio, the structural integrity of the transaction, the roles of external counterparties and the protection provided by credit enhancement.

  • GlobeNewswire26 days ago

    Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness

    November 16, 2018 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness. This approval is a result of clinical trials led by the non-profit research and development organization DNDi and an application submitted by Sanofi.

  • Bolsonaro Taps Santander's Campos for Brazil's Central Bank
    Bloomberg27 days ago

    Bolsonaro Taps Santander's Campos for Brazil's Central Bank

    Campos Neto, Treasury director for the Americas at Banco Santander, will replace Ilan Goldfajn, according to a text message from incoming Finance Minister Paulo Guedes. The appointment needs to be approved by Congress.

  • Hedge Funds Are Buying Banco Santander, S.A. (SAN)
    Insider Monkey28 days ago

    Hedge Funds Are Buying Banco Santander, S.A. (SAN)

    “Market volatility has picked up again over the past few weeks. Headlines highlight risks regarding interest rates, the Fed, China, house prices, auto sales, trade wars, and more. Uncertainty abounds. But doesn’t it always? I have no view on whether the recent volatility will continue for a while, or whether the market will be back […]

  • Moody's29 days ago

    GUINCHO FINANCE -- Moody's assigns provisional ratings to Guincho Finance Portuguese ABS Notes backed by NPLs to be issued by Hefesto, STC, S.A.

    Rating Action: Moody's assigns provisional ratings to Guincho Finance Portuguese ABS Notes backed by NPLs to be issued by Hefesto, STC, S.A. Moody's has not assigned any ratings to E[25,000,000] Class J Asset-Backed Variable Return Notes due [November 2038] and E[3,100,000] Class R Notes due [November 2038].

  • Bank Notes: Wells Fargo shuffles C-suite, uncovers more mortgage issues
    American City Business Journalslast month

    Bank Notes: Wells Fargo shuffles C-suite, uncovers more mortgage issues

    The bank said that its chief administrative officer and chief auditor have begun leaves of absence from the bank and named new leaders for key parts of the company.

  • Why Banco Santander Brasil Shares Soared 29% in October
    Motley Foollast month

    Why Banco Santander Brasil Shares Soared 29% in October

    Brazilian politics provided an external boost to Santander's share price -- at least temporarily.

  • GlobeNewswirelast month

    Sanofi: ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) was associated with fewer deaths from any cause

    November 11, 2018 - New analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association (AHA) Scientific Sessions 2018. Praluent® (alirocumab) was associated with fewer deaths from any cause among patients who had previously experienced a heart attack or unstable angina (known as acute coronary syndrome, or ACS), and this was enhanced in patients who were followed for at least 3 years and those who had an LDL-C (low-density lipoprotein cholesterol) of 100 mg/dL or higher at baseline.

  • GlobeNewswirelast month

    New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial

    New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial Praluent significantly reduced major adverse.